(Total Views: 469)
Posted On: 02/15/2021 12:24:15 PM
Post# of 153986
Re: KenChowder #77994
No, I meant 2051. If we are going to apply a 30x multiple to revenue, we would first have to agree that LL will be used for COVID for 30 years.
I know that this is an oversimplification, but so thinking that the market cap will reflect approvals that we have not yet obtained.
We are seeking an EUA in COVID. this is not an approval. It may become one, and we all expect approvals in other indications, but that is not how market caps are determined.
COVID EUA will jump start this company for sure, but I dont see triple digit share prices coming from COVID alone. They will come once the other indications (that require longer durations of treatment) are approved.
I know that this is an oversimplification, but so thinking that the market cap will reflect approvals that we have not yet obtained.
We are seeking an EUA in COVID. this is not an approval. It may become one, and we all expect approvals in other indications, but that is not how market caps are determined.
COVID EUA will jump start this company for sure, but I dont see triple digit share prices coming from COVID alone. They will come once the other indications (that require longer durations of treatment) are approved.
(2)
(0)
